sales@businessmarketinsights.com     UK: +442081254005
   

North America Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnosis (Laboratory Tests, and Imaging Tests), and Indication (Pain and Cramping, Diarrhea, Constipation, and Alternating Constipation & Diarrhea)

Code: TIPRE00022062 | Pages: 109 | Industry: Medical Device | Date: May 2021
Covid

Market Introduction

Irritable bowel syndrome (IBS) is defined as gastro-intestinal disorder causing discomfort in the stomach, along with wind, diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests.

 

Market Overview and Dynamics

The North America irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 1,529.08 million by 2028 from US$ 950.83 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable bowel syndrome and associated conditions and advancements in diagnostics of syndrome. On the other hand, challenges in diagnosis of IBS are likely to restraint the growth of market during the forecast years.

 

Key Market Segments

Based on the diagnosis, the North America irritable bowel syndrome (IBS) diagnostics market was segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held a larger share of the market and is expected to grow at a faster rate during the coming years.

Based on indication, the North America irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation & diarrhea. The pain and cramping segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the North America irritable bowel syndrome (IBS) diagnostics market are American Society for Gastrointestinal Endoscopy (ASGE), Centers for Disease Control and Prevention (CDC) and International Foundation for Gastrointestinal Disorders (IFFGD).

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of North America irritable bowel syndrome (IBS) diagnostics market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the North America irritable bowel syndrome (IBS) diagnostics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America irritable bowel syndrome (IBS) diagnostics market.

 

NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS MARKET SEGMENTATION

By Diagnosis

  • Laboratory Tests
    • Lactose Intolerance Tests
    • Breath Test for Bacterial Overgrowth
    • Stool Tests
    • Blood Tests
  • Imaging Tests
    • CT Scan or X-ray
    • Upper Endoscopy
    • Endoscopy

By Indication

  • Pain and Cramping
  • Diarrhea
  • Constipation
  • Alternating Constipation & Diarrhea

 

By Country

  • US
  • Canada
  • Mexico

 

Company Profiles

  • Commonwealth Diagnostics International
  • Genova Diagnostics
  • Gemelli Biotech
  • Prometheus Laboratories
  • Inova Diagnostics, Inc
  • Biohit Oyj
  • Aerodiagnostics, LLC.
  • Metabolic Solutions, Inc
  • Sysmex Corporation (Sysmex Europe GmbH)
  • BÜHLMANN Laboratories AG
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Irritable Bowel Syndrome (IBS) Diagnostics Market – By Diagnosis

1.3.2        North America Irritable Bowel Syndrome (IBS) Diagnostics Market – By Indication

1.3.3        North America Irritable Bowel Syndrome (IBS) Diagnostics Market– By Country

2.           Irritable Bowel Syndrome (IBS) Diagnostics Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Irritable Bowel Syndrome (IBS) Diagnostics Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Expert Opinion

5.           Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions

5.1.2        Increasing Number of FDA Approvals and Diagnostics Developments

5.2         Market Restraint

5.2.1        Challenges in Diagnosis of IBS

5.3         Future Trend

5.3.1        Development of Medical Devices for the Diagnosis of Irritable bowel syndrome

5.4         Impact analysis

6.           Irritable Bowel Syndrome (IBS) Diagnostics Market– North America Analysis

6.1         North America Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Forecast and Analysis

7.           Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis– by Diagnosis

7.1         Overview

7.2         Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)

7.3         Laboratory Tests

7.3.1        Overview

7.3.2        Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Lactose Intolerance Tests

7.3.3.1          Overview

7.3.3.2          Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Breath Test for Bacterial Overgrowth

7.3.4.1          Overview

7.3.4.2          Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5        Stool Tests

7.3.5.1          Overview

7.3.5.2          Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6        Blood Tests

7.3.6.1          Overview

7.3.6.2          Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Imaging Tests

7.4.1        Overview

7.4.2        Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        CT-Scan or X-ray

7.4.3.1          Overview

7.4.3.2          CT-Scan or X-ray: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Upper Endoscopy

7.4.4.1          Overview

7.4.4.2          Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Colonoscopy

7.4.5.1          Overview

7.4.5.2          Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – By Indication

8.1         Overview

8.2         Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)

8.3         Pain and Cramping

8.3.1        Overview

8.3.2        Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Diarrhea

8.4.1        Overview

8.4.2        Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Constipation

8.5.1        Overview

8.5.2        Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.6         Alternating Constipation & Diarrhoea

8.6.1        Overview

8.6.2        Alternating Constipation & Diarrhoea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

9.           Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis and Forecasts To 2028 – North America Analysis

9.1         North America: Irritable Bowel Syndrome (IBS) Diagnostics Market

9.1.1        Overview

9.1.2        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)

9.1.3        US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1          US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2          US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1          US: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.2.2          US: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.3          US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication– Revenue and Forecast to 2028 (USD Million)

9.1.4        Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.4.1          Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.4.2          Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)

9.1.4.2.1          Canada: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.4.2.2          Canada: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.4.3          Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.1.5        Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.1          Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.2          Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.1.5.2.1          Mexico: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.5.2.2          Mexico: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.5.3          Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

10.        Impact of COVID-19 Pandemic on North America Irritable Bowel Syndrome (IBS) Diagnostics Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Irritable Bowel Syndrome (IBS) Diagnostics Market– Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

12.        Company Profiles

12.1      Commonwealth Diagnostics International

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Genova Diagnostics

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Gemelli Biotech

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Prometheus Laboratories

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Inova Diagnostics, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Biohit Oyj

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Aerodiagnostics, LLC.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Metabolic Solutions, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Sysmex Corporation (Sysmex Europe GmbH)

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   BÜHLMANN Laboratories AG

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)

Table 2.             US: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             US: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication-Revenue and Forecast to 2028 (USD Million)

Table 5.             Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             Canada: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 9.             Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Mexico: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Glossary of Terms, Irritable Bowel Syndrome (IBS) Diagnostics Market

LIST OF FIGURES

Figure 1.           Irritable Bowel Syndrome (IBS) Diagnostics Market Segmentation

Figure 2.           Irritable Bowel Syndrome (IBS) Diagnostics Segmentation, By Region

Figure 3.           North America Irritable Bowel Syndrome (IBS) Diagnostics Market Overview

Figure 4.           Laboratory Tests Held Largest Share of Diagnosis Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market

Figure 5.           Pain and Cramping Held Largest Share of Indication Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market

Figure 6.           North America Irritable Bowel Syndrome (IBS) Diagnostics Market– Leading Country Markets (US$ Million)

Figure 7.           North America: PEST Analysis

Figure 8.           Irritable Bowel Syndrome (IBS) Diagnostics Market Impact Analysis of Driver and Restraints

Figure 9.           North America Irritable Bowel Syndrome (IBS) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)

Figure 11.        Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        CT-Scan or X-ray: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)

Figure 21.        Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Alternating Constipation & Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)

Figure 26.        North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)

Figure 27.        US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in North American Countries

 

  1. Commonwealth Diagnostics International
  2. Genova Diagnostics
  3. Gemelli Biotech
  4. Prometheus Laboratories
  5. Inova Diagnostics, Inc
  6. Biohit Oyj
  7. Aerodiagnostics, LLC.
  8. Metabolic Solutions, Inc
  9. Sysmex Corporation (Sysmex Europe GmbH)
  10. BÜHLMANN Laboratories AG
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America irritable bowel syndrome (ibs) diagnostics market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the North America irritable bowel syndrome (ibs) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 


Related Tags North America Irritable Bowel Syndrome (IBS) Diagnostics Market North America Irritable Bowel Syndrome (IBS) Diagnostics Market Research North America Irritable Bowel Syndrome (IBS) Diagnostics Market Insight North America Irritable Bowel Syndrome (IBS) Diagnostics Market Trends North America Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast North America Irritable Bowel Syndrome (IBS) Diagnostics Market Share North America Irritable Bowel Syndrome (IBS) Diagnostics Market 2028 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Growth North America Irritable Bowel Syndrome (IBS) Diagnostics Industry Sector North America Irritable Bowel Syndrome (IBS) Diagnostics PDF Report North America Irritable Bowel Syndrome (IBS) Diagnostics Analysis North America Irritable Bowel Syndrome (IBS) Diagnostics Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000